UPDATE : Tuesday, July 23, 2019
상단여백
FDA starts inspecting SK Biopharm’s epilepsy treatment by Lee Han-soo 2019-02-07 16:01
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment by Lee Han-soo 2019-02-07 14:40
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales by Kim Yun-mi 2019-02-07 14:40
FDA OKs Daewoong’s BTX by Lee Han-soo 2019-02-07 11:09
Pfizer feeling bittersweet over Korea’s biosimilars by Lee Han-soo 2019-02-01 17:04
라인
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease by Kim Yun-mi 2019-02-01 17:02
‘Alunbrig works better for ALK-positive non-small cell lung cancer’ by Kim Yun-mi 2019-02-01 15:38
Medytox, Daewoong continue to squabble over BTX by Lee Han-soo 2019-02-01 15:36
Santen Pharma to sell Huonland’s eye drop in China by Lee Han-soo 2019-02-01 11:56
14 pharmaceuticals to release gastritis generic drugs soon by Lee Hye-seon 2019-02-01 11:55
라인
AbClon transfers target antibody technology to GC Labcell by Lee Han-soo 2019-01-31 16:23
Novo Nordisk’s growth hormone injection gets expanded coverage by Lee Han-soo 2019-01-31 15:18
‘Pseudoephedrine-containing drugs could cause acute skin reaction’  by Lee Hye-seon 2019-01-31 14:34
Kwangdong dismisses rumors of terminating sales for Contrav by Lee Han-soo 2019-01-31 14:32
Ipsen’s renal cancer drug Carbometyx gets insurance benefit by Park Gi-taek 2019-01-31 11:13
라인
₩4.7 billion spent on compensation for side effect injuries in 4 years by Lee Hye-seon 2019-01-30 17:18
Pfizer’s lung cancer drug Xalkori threatened by new rivals by Kim Yun-mi 2019-01-30 12:34
Biogen, NHIS begin price talk for spinal muscular atrophy treatment by Lee Han-soo 2019-01-30 11:43
GC to stop making 1st thrombolytic agent amid poor sales by Lee Han-soo 2019-01-29 16:44
Sanofi gets nod to increase dosage for multiple sclerosis treatment by Lee Han-soo 2019-01-28 17:02
여백
여백
여백
Back to Top